In silico studies and synthesis of novel heterocyclic compounds as agonist/antagonist for targets involved in type-2 diabetes mellitus
Nath, Virendra
In silico studies and synthesis of novel heterocyclic compounds as agonist/antagonist for targets involved in type-2 diabetes mellitus by Virendra Nath; guided by Vipin Kumar - 2022 - xvii, 302p. Hardback
Annexure I (i to lii) and Annexure II (liii to lvii) at the end.
Drug Design Diabetes Mellitus
616.462061 / N19I
In silico studies and synthesis of novel heterocyclic compounds as agonist/antagonist for targets involved in type-2 diabetes mellitus by Virendra Nath; guided by Vipin Kumar - 2022 - xvii, 302p. Hardback
Annexure I (i to lii) and Annexure II (liii to lvii) at the end.
Drug Design Diabetes Mellitus
616.462061 / N19I
